Luis I. Garcia hernandez - Related publications

Neurobiology Universidad Veracruzana, Alto Lucero, Veracruz, Mexico 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Karim N, Khan H, Khan I, Guo O, Sanchez ES, Rastrelli L, Kamal MA. An increasing role of polyphenols as novel therapeutics for Alzheimer's: A review. Medicinal Chemistry (Shariqah (United Arab Emirates)). PMID 31702507 DOI: 10.2174/1573406415666191105154407   
2019 Peña-Bautista C, Flor L, López-Nogueroles M, García L, Ferrer I, Baquero M, Vento M, Cháfer-Pericás C. Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: diagnosis utility. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 31678274 DOI: 10.1016/j.cca.2019.10.023   
2019 Hampel H, Vergallo A, Afshar M, Akman-Anderson L, Arenas J, Benda N, Batrla R, Broich K, Caraci F, Cuello AC, Emanuele E, Haberkamp M, Kiddle SJ, Lucía A, Mapstone M, et al. Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
. Dialogues in Clinical Neuroscience. 21: 177-191. PMID 31636492   
2019 Zhu Y, Peng L, Hu J, Chen Y, Chen F. Current anti-Alzheimer's disease effect of natural products and their principal targets. Journal of Integrative Neuroscience. 18: 327-339. PMID 31601083 DOI: 10.31083/j.jin.2019.03.1105   
2019 Dhakal S, Kushairi N, Phan CW, Adhikari B, Sabaratnam V, Macreadie I. Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer's Disease. International Journal of Molecular Sciences. 20. PMID 31615073 DOI: 10.3390/ijms20205090   
2019 Canevelli M, Bacigalupo I, Gervasi G, Lacorte E, Massari M, Mayer F, Vanacore N, Cesari M. Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF. Frontiers in Aging Neuroscience. 11: 282. PMID 31680936 DOI: 10.3389/fnagi.2019.00282   
2019 Iqbal K, Liu F, Gong C, Dai C, Hu W. Why delay in effective treatment for Alzheimer's disease and related conditions. Progress in Molecular Biology and Translational Science. 168: 243-256. PMID 31699318 DOI: 10.1016/bs.pmbts.2019.08.002   
2019 Caruso A, Nicoletti F, Gaetano A, Scaccianoce S. Risk Factors for Alzheimer's Disease: Focus on Stress. Frontiers in Pharmacology. 10: 976. PMID 31551781 DOI: 10.3389/fphar.2019.00976   
2019 Zeng SL, Sudlow LC, Berezin MY. Using Xenopus oocytes in neurological disease drug discovery. Expert Opinion On Drug Discovery. 1-14. PMID 31674217 DOI: 10.1080/17460441.2020.1682993   
2019 Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE. Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions. Journal of Alzheimer's Disease : Jad. PMID 31476157 DOI: 10.3233/JAD-190507   
2019 McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, McNaughton E, Bracoud L, Ahmadi-Abhari S, de Wolf F, Anderson RM, Middleton LT, . Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31564609 DOI: 10.1016/j.jalz.2019.07.010   
2019 Zhang H, Zheng Y. [β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 41: 702-708. PMID 31699204 DOI: 10.3881/j.issn.1000-503X.10875   
2019 Morsy A, Trippier PC. Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31594236 DOI: 10.3233/JAD-190744   
2019 Hettiarachchi SD, Zhou Y, Seven E, Lakshmana MK, Kaushik AK, Chand HS, Leblanc RM. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31647979 DOI: 10.1016/j.jconrel.2019.10.034   
2019 Wang H, Shen Y, Chuang H, Chiu C, Ye Y, Zhao L. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices. Current Alzheimer Research. 16: 659-674. PMID 31580243 DOI: 10.2174/1567205016666190503151648   
2019 Watanabe M, Nakamura Y, Yoshiyama Y, Kagimura T, Kawaguchi H, Matsuzawa H, Tachibana Y, Nishimura K, Kubota N, Kobayashi M, Saito T, Tamura K, Sato T, Takahashi M, , et al. Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 398-408. PMID 31517028 DOI: 10.1016/j.trci.2019.07.004   
2019 Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathologica. PMID 31555895 DOI: 10.1007/s00401-019-02077-x   
2019 Kisby B, Jarrell JT, Agar ME, Cohen DS, Rosin ER, Cahill CM, Rogers JT, Huang X. Alzheimer's Disease and Its Potential Alternative Therapeutics. Journal of Alzheimer's Disease & Parkinsonism. 9. PMID 31588368 DOI: 10.4172/2161-0460.1000477   
2019 Joshi P, Kawade V, Dhulap S, Goel M. Unlocking the concealed targets using system biology mapping for Alzheimer's disease. Pharmacological Reports : Pr. 71: 1104-1107. PMID 31634797 DOI: 10.1016/j.pharep.2019.06.012   
2019 Chan HH, Koh RY, Lim CL, Leong CO. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease. Current Alzheimer Research. PMID 31642777 DOI: 10.2174/1567205016666191023102422   
2019 Provensi G, Carta F, Nocentini A, Supuran CT, Casamenti F, Passani MB, Fossati S. A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease. International Journal of Molecular Sciences. 20. PMID 31554165 DOI: 10.3390/ijms20194724   
2019 Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ, Cardoso SM, Cruz MT. Is Alzheimer's disease an inflammasomopathy? Ageing Research Reviews. 100966. PMID 31577960 DOI: 10.1016/j.arr.2019.100966   
2019 Nolan A, De Paula Franca Resende E, Petersen C, Neylan K, Spina S, Huang E, Seeley W, Miller Z, Grinberg LT. Astrocytic Tau Deposition Is Frequent in Typical and Atypical Alzheimer Disease Presentations. Journal of Neuropathology and Experimental Neurology. PMID 31626288 DOI: 10.1093/jnen/nlz094   
2019 Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 179: 312-339. PMID 31564456 DOI: 10.1016/j.cell.2019.09.001   
2019 Zhang Z, Shen Q, Wu X, Zhang D, Xing D. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models. Aging Cell. e13054. PMID 31663252 DOI: 10.1111/acel.13054   
2019 Loera-Valencia R, Ismail MA, Nilsson P, Winblad B. Restoring synaptic function through multimodal therapeutics. Progress in Molecular Biology and Translational Science. 168: 257-275. PMID 31699320 DOI: 10.1016/bs.pmbts.2019.07.003   
2019 Guan R, Wen X, Liang Y, Xu D, He B, Feng X. Trends in Alzheimer's Disease Research Based upon Machine Learning Analysis of PubMed Abstracts. International Journal of Biological Sciences. 15: 2065-2074. PMID 31592230 DOI: 10.7150/ijbs.35743   
2019 Pousinha PA, Mouska X, Bianchi D, Temido-Ferreira M, Rajão-Saraiva J, Gomes R, Fernandez SP, Salgueiro-Pereira AR, Gandin C, Raymond EF, Barik J, Goutagny R, Bethus I, Lopes LV, Migliore M, et al. The Amyloid Precursor Protein C-Terminal Domain Alters CA1 Neuron Firing, Modifying Hippocampus Oscillations and Impairing Spatial Memory Encoding. Cell Reports. 29: 317-331.e5. PMID 31597094 DOI: 10.1016/j.celrep.2019.08.103   
2019 Bellozi PMQ, Gomes GF, Machado da Silva MC, Vieira de Assis Lima I, Batista CRÁ, de Oliveira Carneiro Junior W, Dória JG, Vieira ÉLM, Vieira RP, de Freitas RP, Ferreira CN, Candelario-Jalil E, Wyss-Coray T, Ribeiro FM, de Oliveira ACP. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mice models of Alzheimer's disease. Neuropharmacology. 107785. PMID 31541651 DOI: 10.1016/j.neuropharm.2019.107785   
2019 Liu K, Ma C, Su J, Sun Y, Shen N, Li B, Feng Y, Yang X, Wu H, Zhang H, Herrmann A, Tanzi R, Zhang C. Significant upregulation of Alzheimer's β-amyloid levels in living system induced by extracellular elastin polypeptides. Angewandte Chemie (International Ed. in English). PMID 31609093 DOI: 10.1002/anie.201912399   
2019 Woods JJ, Skelding KA, Martin KL, Aryal R, Sontag E, Johnstone DM, Horvat JC, Hansbro PM, Milward EA. Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology. Brain, Behavior, and Immunity. PMID 31626972 DOI: 10.1016/j.bbi.2019.10.014   
2019 Verkhratsky A, Parpura V, Rodriguez-Arellano JJ, Zorec R. Astroglia in Alzheimer's Disease. Advances in Experimental Medicine and Biology. 1175: 273-324. PMID 31583592 DOI: 10.1007/978-981-13-9913-8_11   
2019 Hemonnot AL, Hua J, Ulmann L, Hirbec H. Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities. Frontiers in Aging Neuroscience. 11: 233. PMID 31543810 DOI: 10.3389/fnagi.2019.00233   
2019 Hemonnot AL, Hua J, Ulmann L, Hirbec H. Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities. Frontiers in Aging Neuroscience. 11: 233. PMID 31543810 DOI: 10.3389/fnagi.2019.00233   
2019 Smilnak GJ, Deans JR, Doraiswamy PM, Stinnett S, Whitson HE, Lad EM. Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study. Plos One. 14: e0223199. PMID 31568508 DOI: 10.1371/journal.pone.0223199   
2019 Bukenya F, Nerissa C, Serres S, Pardon MC, Bai L. An automated method for segmentation and quantification of blood vessels in histology images. Microvascular Research. 103928. PMID 31676310 DOI: 10.1016/j.mvr.2019.103928   
2019 Kabir MT, Uddin MS, Begum MM, Thangapandiyan S, Rahman MS, Aleya L, Mathew B, Ahmed M, Ashraf GM, Barreto GE. Cholinesterase Inhibitors for Alzheimer Disease: Multitargeting Strategy based on Anti-Alzheimer's Drugs Repositioning. Current Pharmaceutical Design. PMID 31593530 DOI: 10.2174/1381612825666191008103141   
2019 Jeong W, Lee H, Cho S, Seo J. ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease. Molecules and Cells. PMID 31711277 DOI: 10.14348/molcells.2019.0200   
2019 Grizzanti J, Corrigan R, Servizi S, Casadesus G. Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology? Journal of Neurology & Neuromedicine. 4: 12-16. PMID 31511851 DOI: 10.29245/2572.942X/2019/1.1212   
2019 Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A. The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia. Frontiers in Aging Neuroscience. 11: 236. PMID 31551756 DOI: 10.3389/fnagi.2019.00236   
2019 Gao J, Wang L, Gao C, Arakawa H, Perry G, Wang X. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165580. PMID 31678156 DOI: 10.1016/j.bbadis.2019.165580   
2019 Villeneuve SC, Houot M, Cacciamani F, Verrijp M, Dubois B, Sikkes S, Epelbaum S, . Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 553-562. PMID 31650012 DOI: 10.1016/j.trci.2019.08.009   
2019 Carvalho K, Faivre E, Pietrowski MJ, Marques X, Gomez-Murcia V, Deleau A, Huin V, Hansen JN, Kozlov S, Danis C, Temido-Ferreira M, Coelho JE, Mériaux C, Eddarkaoui S, Gras SL, ... , et al. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain : a Journal of Neurology. PMID 31599329 DOI: 10.1093/brain/awz288   
2019 Pesini A, Iglesias E, Bayona-Bafaluy MP, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Andrés-Benito P, Montoya J, Ferrer I, Pesini P, Ruiz-Pesini E. Brain pyrimidine nucleotide synthesis and Alzheimer disease. Aging. 11. PMID 31560653 DOI: 10.18632/aging.102328   
2019 Lansang P, Lam JM, Marcoux D, Prajapati VH, Spring S, Lara-Corrales I. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 23: 19S-31S. PMID 31692376 DOI: 10.1177/1203475419882647   
2019 Liu PP, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal Transduction and Targeted Therapy. 4: 29. PMID 31637009 DOI: 10.1038/s41392-019-0063-8   
2019 Tiepolt S, Patt M, Aghakhanyan G, Meyer PM, Hesse S, Barthel H, Sabri O. Current radiotracers to image neurodegenerative diseases. Ejnmmi Radiopharmacy and Chemistry. 4: 17. PMID 31659510 DOI: 10.1186/s41181-019-0070-7   
2019 Li TR, Wang XN, Sheng C, Li YX, Li FZ, Sun Y, Han Y. Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease. Mechanisms of Ageing and Development. 111175. PMID 31678325 DOI: 10.1016/j.mad.2019.111175   
2019 Jessen F. What are we trying to prevent in Alzheimer disease? Dialogues in Clinical Neuroscience. 21: 27-34. PMID 31607778   
2019 Bejanin A, Murray ME, Martin P, Botha H, Tosakulwong N, Schwarz CG, Senjem ML, Chételat G, Kantarci K, Jack CR, Boeve BF, Knopman DS, Petersen RC, Giannini C, Parisi JE, et al. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. Brain : a Journal of Neurology. PMID 31562527 DOI: 10.1093/brain/awz277